GIPR and neuroendocrine neoplasm: GIPR, short for gastric inhibitory polypeptide receptor, has been regarded as a promising target for imaging and therapy in gastric and neuroendocrine tumors, and it has also been reported that GIPR is significantly overexpressed in stomach tissue compared with normal tissue (Sherman et al., 2013, 2014).